{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:49:27Z","timestamp":1781059767785,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","award":["2883"],"award-info":[{"award-number":["2883"]}],"id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jcjd.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T21:04:39Z","timestamp":1676063079000},"page":"263-271.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Canadian Cystic Fibrosis\u2013related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care"],"prefix":"10.1016","volume":"47","author":[{"given":"Kathryn J.","family":"Potter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-8060","authenticated-orcid":false,"given":"Ad\u00e8le","family":"Coriati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3594-199X","authenticated-orcid":false,"given":"Patrick","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry C.","family":"Lands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha L.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8362-596X","authenticated-orcid":false,"given":"Anne","family":"Bonhoure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0379-4427","authenticated-orcid":false,"given":"Josephine","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9mah","family":"Tagougui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Jober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0402-4240","authenticated-orcid":false,"given":"Elizabeth T.","family":"Rosolowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Y.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-8673","authenticated-orcid":false,"given":"Peter A.","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4706-5170","authenticated-orcid":false,"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-5885","authenticated-orcid":false,"given":"Tamizan","family":"Kherani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2023.02.002_bib1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jcjd.2016.08.221","article-title":"Screening for cystic fibrosis\u2013related diabetes: Matching pathophysiology and addressing current challenges","volume":"40","author":"Boudreau","year":"2016","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2023.02.002_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.702823","article-title":"The potential causes of cystic fibrosis\u2013related diabetes","volume":"12","author":"Coderre","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2023.02.002_bib3","series-title":"The Canadian Cystic Fibrosis Registry 2020 Annual Data Report","year":"2022"},{"key":"10.1016\/j.jcjd.2023.02.002_bib4","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"Suppl. 27","key":"10.1016\/j.jcjd.2023.02.002_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis\u2013related diabetes in children and adolescents","volume":"19","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcjd.2023.02.002_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.673539","article-title":"Diabetes and prediabetes in children with cystic fibrosis: A systematic review of the literature and recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED)","volume":"12","author":"Mozzillo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2023.02.002_bib7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/08870446.2016.1183008","article-title":"How patients' representations of cystic fibrosis\u2013related diabetes inform their health behaviours","volume":"31","author":"Sylvain","year":"2016","journal-title":"Psychol Health"},{"key":"10.1016\/j.jcjd.2023.02.002_bib8","doi-asserted-by":"crossref","first-page":"e3901","DOI":"10.1210\/clinem\/dgab384","article-title":"Combined indeterminate and impaired glucose tolerance is a novel group at high risk of cystic fibrosis\u2013related diabetes","volume":"106","author":"Potter","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2023.02.002_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpeds.2007.09.025","article-title":"Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis","volume":"152","author":"Bismuth","year":"2008","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jcjd.2023.02.002_bib10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1515\/jpem-2017-0005","article-title":"Cystic-fibrosis related\u2013diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function","volume":"30","author":"Terliesner","year":"2017","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2023.02.002_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jcf.2020.11.022","article-title":"Influence of pre-diabetic and pancreatic exocrine states on pulmonary and nutritional status in adults with cystic fibrosis","volume":"20","author":"Potter","year":"2021","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2023.02.002_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.311.7006.655","article-title":"Glucose tolerance in patients with cystic fibrosis: Five year prospective study","volume":"311","author":"Lanng","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2023.02.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcjd.2018.11.001","article-title":"What is the real usefulness of glycated hemoglobin levels for diabetes screening in patients with cystic fibrosis?","volume":"43","author":"Boudreau","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2023.02.002_bib14","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis\u2013related diabetes without fasting hyperglycemia: Results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.02.002_bib15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jcf.2018.05.005","article-title":"Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis\u2013related diabetes","volume":"17","author":"Frost","year":"2018","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2023.02.002_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ajcn.81.2.421","article-title":"Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis","volume":"81","author":"Rafii","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcjd.2023.02.002_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0293-2020","article-title":"Cystic fibrosis\u2013related diabetes and lung disease: An update","volume":"30","author":"Prentice","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jcjd.2023.02.002_bib18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1742395308094240","article-title":"Living with cystic fibrosis\u2013related diabetes or type 1 diabetes mellitus: A comparative study exploring health-related quality of life and patients' reported experiences of hypoglycaemia","volume":"4","author":"Tierney","year":"2008","journal-title":"Chronic Illn"},{"key":"10.1016\/j.jcjd.2023.02.002_bib19","first-page":"100","article-title":"Patient and parent perceptions of the diagnosis and management of cystic fibrosis\u2013related diabetes","volume":"1","author":"Millington","year":"2014","journal-title":"J\u00a0Clin Transl Endocrinol"},{"key":"10.1016\/j.jcjd.2023.02.002_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S2213-8587(17)30400-X","article-title":"Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: A multicentre, open-label, randomised trial","volume":"6","author":"Ballmann","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcjd.2023.02.002_bib21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ppul.20831","article-title":"Management of cystic fibrosis related diabetes: A survey of UK cystic fibrosis centers","volume":"43","author":"Mohan","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcjd.2023.02.002_bib22","article-title":"Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: A French survey from the 47 centers","volume":"28","author":"Weiss","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcjd.2023.02.002_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1515\/jpem-2017-0122","article-title":"Sensitivity and specificity of cystic fibrosis-related diabetes screening methods: Which test should be the reference method?","volume":"30","author":"Boudreau","year":"2017","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2023.02.002_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcjd.2018.11.005","article-title":"Validation of a stepwise approach using glycated hemoglobin levels to reduce the number of required oral glucose tolerance tests to screen for cystic fibrosis\u2013related diabetes in adults","volume":"43","author":"Boudreau","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2023.02.002_bib25","first-page":"CD013755","article-title":"Continuous glucose monitoring systems for monitoring cystic fibrosis\u2013related diabetes","volume":"11","author":"Toner","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcjd.2023.02.002_bib26","first-page":"CD004730","article-title":"Insulin and oral agents for managing cystic fibrosis-related diabetes","volume":"4","author":"Onady","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcjd.2023.02.002_bib27","article-title":"Cystic fibrosis-related diabetes: The patient perspective","volume":"26","author":"Mason","year":"2021","journal-title":"J\u00a0Clin Transl Endocrinol"},{"key":"10.1016\/j.jcjd.2023.02.002_bib28","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc17-2419","article-title":"Hemoglobin A(1c) accurately predicts continuous glucose monitoring\u2013derived average glucose in youth and young adults with cystic fibrosis","volume":"41","author":"Chan","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.02.002_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcjd.2018.04.008","article-title":"Cystic fibrosis\u2013related diabetes screening in adults: A gap analysis and evaluation of accuracy of glycated hemoglobin levels","volume":"43","author":"Gilmour","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2023.02.002_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jcjd.2021.03.005","article-title":"Glycated hemoglobin as a first-line screening test for cystic fibrosis\u2012related diabetes and impaired glucose tolerance in children with cystic fibrosis: A validation study","volume":"45","author":"Racine","year":"2021","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2023.02.002_bib31","first-page":"CD004730","article-title":"Drug treatments for managing cystic fibrosis\u2013related diabetes","volume":"10","author":"Onady","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcjd.2023.02.002_bib32","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diacare.24.10.1706","article-title":"Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis\u2013related diabetes","volume":"24","author":"Moran","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2023.02.002_bib33","first-page":"4","article-title":"A\u00a0review of the treatment of type 2 diabetes in children","volume":"20","author":"Onge","year":"2015","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"key":"10.1016\/j.jcjd.2023.02.002_bib34","series-title":"Endotext. South Dartmouth (MA)","article-title":"Oral and injectable (non-insulin) pharmacological agents for the treatment of type 2 diabetes","author":"Feingold","year":"2000"},{"key":"10.1016\/j.jcjd.2023.02.002_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6823-6-4","article-title":"Insulin versus oral agents in the management of cystic\u00a0fibrosis related diabetes: A case based study","volume":"6","author":"Onady","year":"2006","journal-title":"BMC Endocr Disord"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267123000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267123000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:40:58Z","timestamp":1778816458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267123000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1499267123000345"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2023.02.002","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadian Cystic Fibrosis\u2013related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}